Modeling Ewing sarcoma tumors in vitro with 3D scaffolds

Area of Science:

• Oncology
• Biomaterials Science
• Cancer Biology

Background:

• The tumor microenvironment significantly impacts cancer progression and metastasis.
• Conventional 2D cell cultures inadequately model the complex microenvironmental cues crucial for cancer research.
• 3D cell-cell and cell-extracellular matrix interactions are vital but poorly represented in 2D models.

Purpose of the Study:

• To establish an ex vivo 3D Ewing sarcoma model that mimics human tumor characteristics.
• To compare the drug response and molecular profiles of Ewing sarcoma cells in 3D versus 2D cultures.
• To evaluate the potential of the 3D model for preclinical antineoplastic drug testing.

Main Methods:

• Development of a 3D Ewing sarcoma model using porous electrospun poly(ε-caprolactone) scaffolds.
• Culturing Ewing sarcoma cells in both 3D scaffolds and conventional 2D monolayer systems.
• Analysis of drug resistance, morphology, growth kinetics, and protein expression, particularly the IGF-1R/mTOR pathway.

Main Results:

• The 3D Ewing sarcoma model closely replicated human tumor morphology, growth, and protein expression.
• Ewing sarcoma cells in the 3D model demonstrated increased resistance to cytotoxic drugs compared to 2D cultures.
• Significant differences in the insulin-like growth factor-1 receptor/mammalian target of rapamycin pathway expression were observed in the 3D model.

Conclusions:

• The established 3D ex vivo model provides a more biologically relevant platform for studying Ewing sarcoma.
• This 3D bone microenvironment model may enhance the preclinical evaluation of novel antineoplastic drugs.
• The model holds potential for mechanistic studies of bone sarcomas and improving therapeutic strategies.